Μετάβαση στο περιεχόμενο

Ετικέταtrastuzumab

US FDA Approves ONTRUZANT® (trastuzumab-dttb), Samsung Bioepis’ First Oncology Medicine in the United States

  Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!!    Samsung Bioepis Co., Ltd. today announced that the U.S.Food and Drug Administration (FDA) has approved ONTRUZANT® (trastuzumab-dttb), a biosimilar … Continue Reading US FDA Approves ONTRUZANT® (trastuzumab-dttb), Samsung Bioepis’ First Oncology Medicine in the United States

CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers

  For years, the foundations of cancer treatment were surgery, chemotherapy, and radiation therapy. Over the last two decades, targeted therapies like imatinib (Gleevec®)and trastuzumab (Herceptin®)—drugs that target cancer cells by homing in on specific molecular … Continue Reading CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers